Pancreatic cancer remains the fourth leading cause of cancer-related deaths in the United
States. Risk factors include family history, smoking, chronic pancreatitis, obesity, diabetes …

Although only 32,000 new cases of adenocarcinoma of the pancreas occur in the United
States each year, it is the fourth leading cause of cancer deaths in this country. The overall …

Purpose To update the Potentially Curable Pancreatic Cancer: American Society of Clinical
Oncology Clinical Practice Guideline published on May 31, 2016. The October 2016 update …

ContextThe role of adjuvant therapy in resectable pancreatic cancer is still uncertain, and no
recommended standard exists. ObjectiveTo test the hypothesis that adjuvant chemotherapy …

Importance Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer,
with approximately 60 430 new diagnoses expected in 2021 in the US. The incidence of …

Importance The prognosis for patients with pancreatic cancer is poor, even after resection
with curative intent. Gemcitabine-based chemotherapy is standard treatment for advanced …

Pancreatic cancer is a common, highly lethal disease with a rising incidence. In the last
years continued efforts in pancreatic cancer research have led to a change in the classic …

Pancreatic cancer remains a fearsome disease. New insights into the molecular
pathogenesis may influence choice of treatment modalities and provide avenues for novel …

Pancreatic cancer still remains a significant, unresolved therapeutic challenge and is the
most lethal type of gastrointestinal cancer with a 5-year survival rate of 5%. Adjuvant …

The physician must suspect pancreatic cancer in patients older than age 40 years who
present with minimal vague symptoms. The presence of common disorders such as …